ワッタナ・プライヌム

Recent publications · Crossref

5 total works indexed

1. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

   · 2022 · cited 1,169x

2. Probable Person-to-Person Transmission of Avian Influenza A (H5N1)

   · 2005 · cited 641x

3. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

   · 2022 · cited 479x

4. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

   · 2022 · cited 349x

5. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

   · 2024 · cited 289x

via Crossref · CC0

Wikidata facts